{"url_path":"/sec/roiv/8-k/2026-05-20/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","accession_number":"0001635088-26-000060","cik":"0001635088","ticker":"ROIV","issuer_name":"Roivant Sciences Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","primary_entity_key":"0001635088","primary_entity_name":"Roivant Sciences Ltd."},"word_count":137,"has_tables":true,"body_markdown":"Item 2.02    Results of Operations and Financial Condition.\n\nOn May 20, 2026, Roivant Sciences Ltd. (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information set forth under this “Item 2.02 Results of Operations and Financial Condition” (including Exhibit 99.1) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Company pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto."}